This bill includes improved flexibility for the making of COVID-19 orders; the effective management of the laboratory testing regime and systems; the strengthening of the infringement regime, which I've already referred to; improved delegated decision-making—there are issues and there have been issues highlighted, in part, by the Regulations Review Committee, sometimes, about some of the things that I have delegated under the Act, where the Regulations Review Committee have argued that it could be inconsistent with the way the delegation framework in the Act operates, and so we've taken that on board and tried to fix those and amend those. Most of the delegations are pragmatic ones to allow decisions to be taken faster, where they concern individual people without them having to go through a ministerial decision-making process. But we want to make sure that that is transparent and that that is tidy, and so we've made some changes there. Some further changes to support the effective operation of our existing managed isolation and quarantine (MIQ) facilities, and some other technical amendment.